Latest Headlines
-
Carolina Liquid Chemistries Corp. Engages The Veterinary Market By Offering The Seamaty Veterinary Automated Chemistry Analyzer
3/22/2021
Carolina Liquid Chemistries Corp. now offers the Seamaty SMT-120V Veterinary Automated Biochemistry Analyzer. Carolina Liquid Chemistries Corp. has provided products for over 25 years to service the various needs of clinical laboratories by providing affordable, high-quality laboratory equipment and reagents.
-
DiamiR Announces Acquisition Of CLIA Lab From Interpace Biosciences
3/17/2021
DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into a definitive agreement to acquire a CLIA (Clinical Laboratory Improvement Amendments) certified laboratory in New Haven, CT from Interpace Biosciences, Inc. Subject to specific terms and conditions of the agreement being met, it is anticipated that the transaction will close by the end of April, 2021.
-
Roche Launches Cobas Pure Integrated Solutions Analyser To Help Simplify Operations In Small To Medium Sized Labs
3/17/2021
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of cobas pure integrated solutions in countries accepting the CE mark.3 This new compact analyser combines three technologies1 on a single platform helping to simplify daily operations in labs with limited space and resources.
-
DeepVerge PLC: Microtox® BT Evaluation Of SARS-CoV-2 From Breath Test With Clinical Samples
3/17/2021
DeepVerge (LSE:DVRG.L), the environmental and life science AI company, announces initial data for ongoing Phase III clinical studies on the detection of SARS-CoV-2 on breath samples and identification of confirmed COVID19 positive patients.
-
EUROIMMUN Launches Novel Ultrafast Automated Microscope And Intelligent Software For State-Of-The-Art Diagnostics
3/16/2021
EUROIMMUN, a PerkinElmer, Inc. company, today announced the launch of the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the Company’s well-established EUROLabOfficeTM 4.0 (ELO 4.0) laboratory management software.
-
LifeLabs Completes Over 1.5 Million COVID-19 Molecular Tests
3/16/2021
LifeLabs is pleased to announce its latest milestone in COVID-19 molecular diagnostic testing, completing over 1.5 million tests for Canadians and their health care providers.
-
Geneseeq Inks Deal With Illumina To Develop And Commercialize Comprehensive Cancer In-Vitro Diagnostic NGS Kit In China
3/16/2021
Next-generation sequencing (NGS)-based precision oncology provider Geneseeq Technology Inc. ("Geneseeq"), will collaborate with Illumina, Inc. (NASDAQ: ILMN) ("Illumina") to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer, using Illumina's NextSeq™ 550Dx sequencing platform.
-
Carolina Liquid Chemistries Corp. Becomes Value-Added Distributor For Mindray North America Hematology Systems
3/15/2021
Carolina Liquid Chemistries Corp. announces its value-added distributorship for Mindray North America Hematology Systems. Mindray, a leading global developer, manufacturer, and supplier of medical devices, provides solutions in three core businesses: Patient Monitoring and Life Support, Medical Imaging, and In-Vitro Diagnostics.
-
Fujifilm Receives CE Certificate And Launches A Highly-Sensitive And Rapid Antigen Test Kit For SARS-CoV-2 In Europe Utilizing Silver Halide Amplification Technology
3/15/2021
FUJIFILM Europe GmbH received the CE certificate and thus able to apply the CE mark to and launch an antigen test kit for diagnosis of SARS-CoV-2 infection. Fujifilm is using its proprietary silver amplification immunochromatography method, which is based on silver amplification technology used in the photo-developing process.
-
Agiomix Receives The First ISO 15189 Accreditation For Next Generation Sequencing In The Region
3/14/2021
Agiomix has received the ISO 15189:2012 Accreditation from the Emirates International Accreditation Centre for Next Generation Sequencing clinical assays.